Clinical Trials
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing...
News
NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
“NextPharma is an established and well-respected company, with extensive experience in oral and topical finished dosage forms. As such, it is the ideal buyer...
Clinical Trials
Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio
Intravacc, a world leader in translational research and development of vaccines, announced that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and...
IT & Data Management
CluePoint’s Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management...
News
Brazil approves Sinovac and Astrazeneca Covid-19 vaccines for emergency use
Brazil has granted approval to AstraZeneca and Chinese firm Sinovac Biotech’c Covid-19 vaccines for emergency use, allowing the country to begin inoculation as cases...
News
DARZALEX FASPRO Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. FDA approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of...
News
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read